MMQCI-Maine Molecular Quality Controls Inc.

Maine Molecular Quality Controls, Inc. (MMQCI) is a company founded in January 2000 that specializes in designing, developing, and manufacturing high-quality molecular control products for clinical laboratories. These products are crucial for ensuring the accuracy and reliability of molecular diagnostic tests, including those for inherited diseases, infectious diseases, oncology, and next-generation sequencing panels. MMQCI operates a cGMP-certified facility and offers both standard and custom molecular controls, adhering to best practices and regulatory requirements. The company was established by Joan Gordon and Clark Rundell, who bring extensive experience in clinical laboratory testing and molecular biology. MMQCI's innovative product portfolio reflects its commitment to quality assurance and regulatory compliance, serving clinical laboratories and in vitro diagnostic manufacturers. With a workforce of 51 to 200 employees and annual revenues between $1 million and $5 million, MMQCI has established itself as a respected player in the molecular diagnostics community, supported by funding from the National Institutes of Health and the Maine Technology Institute.

• Employees 60
• Founded 2000
• Annual Revenue $12828000